GS-5801

N/A

Report date: 2025/06/05 16:57:47
NME

Base Information

Drug NameGS-5801
Drug Alias NameGS-5801KDM5-C70KDOAM-21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 5A inhibitorsLysine-specific demethylase 5B inhibitors
TargetsLysine-specific demethylase 5ALysine-specific demethylase 5B
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A